Members
National Clinical Trials Oversight Group - Membership List
Terms of Reference
National Clinical Trials Oversight Group - Terms of Reference
Agendas of Meetings
National Clinical Trials Oversight Group - Agenda -03 July 2025
National Clinical Trials Oversight Group - Agenda -29 May 2025
National Clinical Trials Oversight Group - Agenda - 24 April 2025
National Clinical Trials Oversight Group - Agenda - 27 March 2025
National Clinical Trials Oversight Group - Agenda - 27 February 2025
National Clinical Trials Oversight Group - Agenda - 30 January 2025
National Clinical Trials Oversight Group - Agenda - 12 December 2024
National Clinical Trials Oversight Group - Agenda - 21 November 2024
National Clinical Trials Oversight Group - Agenda - 24 October 2024
National Clinical Trials Oversight Group - Agenda - 26 September 2024
National Clinical Trials Oversight Group - Agenda - 29 August 2024
National Clinical Trials Oversight Group - Agenda - 11 July 2024
Minutes of Meetings
National Clinical Trials Oversight Group - Minutes - 03 July 2025
National Clinical Trials Oversight Group - Minutes - 29 May 2025
National Clinical Trials Oversight Group - Minutes - 24 April 2025
National Clinical Trials Oversight Group - Minutes - 27 March 2025
National Clinical Trials Oversight Group - Minutes - 27 February 2025
National Clinical Trials Oversight Group - Minutes - 30 January 2025
National Clinical Trials Oversight Group - Minutes - 12 December 2024
National Clinical Trials Oversight Group - Minutes - 21 November 2024
National Clinical Trials Oversight Group - Minutes - 24 October 2024
National Clinical Trials Oversight Group - Minutes - 26 September 2024
National Clinical Trials Oversight Group - Minutes - 29 August 2024
National Clinical Trials Oversight Group - Minutes - 11 July 2024
Expected timeframe
The NCTOG will be operational for a period of one year, commencing July 2024 until end of June 2025.
Reporting arrangements
During the 12 months of its operations, the NCTOG will produce two reports to the Minister for Health:
An interim report outlining the challenges involved in conducting clinical trials.
A final report detailing potential solutions to enhance the clinical trials landscape.